why choose us

First received: October 04, 2023

Clinical Trial: Dose-Escalation, Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GB-6002 Local Infiltration in Healthy Male Adults

Study Status: Completed

Recruit Status: RECRUITING

Condition: Pain, Postoperative

Study Type: INTERVENTIONAL


Official Title: A Single Center, Single-blind, Randomized, Dose-escalation, Parallel, Placebo and Active-controlled, Single Dose, Phase 1 Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Phar

Brief Summary: This study is to evaluate the safety and tolerability of single dose of GB-6002 (Ropivacaine) Local Infiltration in healthy male Adults.And, It is to compare pharmacokinetic characteristics of GB-6002 single dose injection with active comparator.

Read more